Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors

ClinicalTrials.gov ID: NCT00090025

Public ClinicalTrials.gov record NCT00090025. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 8:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Multicenter, Open Label, Randomized Study of XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors Not Amenable to Conventional Surgery

Study identification

NCT ID
NCT00090025
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Helsinn Healthcare SA
Industry
Enrollment
248 participants

Conditions and interventions

Interventions

  • 5-Fluorouracil Plus Leucovorin Drug
  • becatecarin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2004
Primary completion
Oct 31, 2006
Completion
Oct 31, 2006
Last update posted
Jan 13, 2009

2004 – 2006

United States locations

U.S. sites
27
U.S. states
19
U.S. cities
27
Facility City State ZIP Site status
University of Alabama at Birmingham Comprehensive Cancer Center Birmingham Alabama 35294
Long Beach VA Medical Center Long Beach California 90822
University of California, Irvine Medical Center Orange California 92868
Sharp Clinical Oncology Research San Diego California 92123
Pacific Hematology Oncology Associates San Francisco California 94115
Yale University School of Medicine New Haven Connecticut 06520
Tampa General Hospital Tampa Florida 33606
Winship Cancer Institute, Emory University Hospital Atlanta Georgia 30322
Carle Clinic Association Urbana Illinois 61801
Medical Consultants, PC c/o Ball Cancer Center Muncie Indiana 47303
Oncology Associates Cedar Rapids Iowa 52403
Louisiana Oncology Associates Lafayette Louisiana 70506
Tufts - New England Medical Center Boston Massachusetts 02111
Josephine Ford Cancer Center at Henry Ford Health System Detroit Michigan 48202
West Michigan Cancer Center Kalamazoo Michigan 49007
Oncology Care Center PLLC Saint Joseph Michigan 49085
Norris Cotton Cancer Center Lebanon New Hampshire 03756
Queens Hospital Center Jamaica New York 11432
SUNY Upstate Medical University Syracuse New York 13210
New York Medical College Valhalla New York 10595
Cancer Treatment and Research Center Bismarck North Dakota 58501
Gabrail Cancer Center Canton Ohio 44718
Case Western Reserve University Cleveland Ohio 44106
Charleston Hematology Oncology, PA Charleston South Carolina 29403
The Sarah Cannon Cancer Center Nashville Tennessee 37203
Western Washington Oncology, Inc. Lacey Washington 98503
University of Wisconsin Comprehensive Cancer Center Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00090025, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 13, 2009 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00090025 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →